Named on 2 rounds in the feed.
Rounds from 2025-09-30 to 2025-11-20
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$320M
across 2 rounds
CO-INVESTORS
24
named beside it
Named on 2 rounds in the feed.
Rounds from 2025-09-30 to 2025-11-20
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Aspen Neuroscience Aspen Neuroscience develops personalized regenerative therapies, specifically autologous iPSC-derived cell replacement therapies for Parkinson's disease. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $115M | 2025-11-20 | [ PART ] |
Crystalys Therapeutics Crystalystx develops therapeutics specifically for treating gout. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $205M | 2025-09-30 | [ PART ] |